Ginkgo bioworks acquires adaptive laboratory evolution company altar

Boston , oct. 4, 2022 /prnewswire/ -- ginkgo bioworks (nyse: dna), the leading horizontal platform for cell programming, today announced the tuck-in acquisition of altar, a french biotechnology company that has developed a proprietary adaptive evolution platform. a fleet of altar's automated adaptive laboratory evolution (ale) instruments will be integrated into ginkgo's foundry to serve customers across food and beverage, biofuels, biomaterials, cosmetics, animal health and human health applications, among others.
DNA Ratings Summary
DNA Quant Ranking